| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Revenue | $24.1M | -32.2% |
| Cost of Revenue | $23.4M | -28.6% |
| Gross Profit | $694K | -74.9% |
| R&D Expense | $412K | -34.9% |
| SG&A Expense | $5.0M | -21.7% |
| Operating Income | -$6.9M | -16.7% |
| Pre-tax Income | -$7.0M | -17.6% |
| Income Tax | -$879K | +0.0% |
| Net Income | -$7.0M |
| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69K | -93.9% |
| Accounts Receivable | $44.8M | +37.3% |
| Inventory | $258K | +89.8% |
| Current Assets | $51.8M | +23.2% |
| Total Assets | $60.8M | +24.6% |
| Current Liabilities | $45.7M | +30.0% |
| Total Liabilities | $45.7M | +30.0% |
| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | +52.3% |
| Capital Expenditures | $20K | +391.3% |
| Investing Cash Flow | -$20K | -391.3% |
| Financing Cash Flow | $2.9M | -63.2% |
| Free Cash Flow | -$3.9M | +52.0% |
| -37.7% |
| EPS (Basic) | -$0.12 | -33.3% |
| EPS (Diluted) | -$0.12 | -33.3% |
| Stockholders' Equity |
| $15.2M |
| +11.2% |